EVALUATING THE HATCH-WAXMAN AMENDMENT’S INFLUENCE ON FDA’S GENERIC MEDICATION APPROVAL PROCESS. (2022). Journal of Pharmaceutical Negative Results, 3393-3405. https://doi.org/10.47750/pnr.2022.13.S06.454